Maya Health raised $4.3M to decentralize psychedelic research. The company is developing a blockchain-based platform that allows the psychedelic community to collaborate, share best practices, and gather real-world data to accelerate pre-clinical research.
This scientist claims she helped end the Cold War with MDMA.
Carol Rosin—a space and missile defense consultant for the US—said she gave MDMA to Soviet scientists and military personnel prior to nuclear negotiations in 1985 (before the drug was illegal).
The plan was created with help from Rick Doblin, the founder of MAPS.
“The thought was that if they can work through their fears and traumas and feel their connection to humanity, then that might be helpful,” Doblin explains.
While some are skeptical if this actually happened, MDMA releases oxytocin (aka the hormone of love and empathy), which could certainly help the opposing sides see eye to eye!
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) changed its guidelines to allow the use of “real-world data” collected from the healthcare system to aid in regulatory approval of new medicines. This will expedite clinical trials and get treatments to patients sooner!
A recent survey revealed how psychedelic therapy is viewed by medical professionals in the American Academy of Addiction Psychiatry.
Of the 145 respondents:
Interest is growing among patients too – the vast majority of specialist said they had discussed psychedelic experiences with at least one patient.
